May Barnhard Investments’s BioCryst Pharmaceuticals BCRX Stock Holding History

May Barnhard Investments’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$490K	Buy	58,774 +28,774	+96%	+$271K	0.2%	69
2026 Q2	$300K	Hold	30,000	–	–	0.12%	74
2026 Q1	$286K	Hold	30,000	–	–	0.14%	72
2025 Q4	$234K	Hold	30,000	–	–	0.11%	80
2025 Q3	$228K	Hold	30,000	–	–	0.11%	80
2025 Q2	$269K	Hold	30,000	–	–	0.13%	78
2025 Q1	$225K	Hold	30,000	–	–	0.11%	85
2024 Q4	$226K	Hold	30,000	–	–	0.11%	77
2024 Q3	$228K	Hold	30,000	–	–	0.11%	77
2024 Q2	$185K	Buy	+30,000	New	+$166K	0.1%	82

Other funds holding BCRX

WCM

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

RHS Financial San Francisco, California $296M AUM 17.24% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

May Barnhard Investments's BCRX Position: Q3 2026 in Review

May Barnhard Investments increased its BioCryst Pharmaceuticals (BCRX) stake by 96% in Q3 2026, buying an estimated $271K and bringing the position to 58,774 shares worth $490K. The position accounts for 0.2% of the portfolio, ranked #69.

May Barnhard Investments first reported a position in BCRX in Q2 2024 and has held it in 10 quarters since. 11 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.

May Barnhard Investments held 58,774 shares of BioCryst Pharmaceuticals worth $490K as of Q3 2026.
May Barnhard Investments bought 28,774 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $271K.
BioCryst Pharmaceuticals made up 0.2% of May Barnhard Investments's portfolio in Q3 2026, its #69 holding.
May Barnhard Investments first reported a position in BioCryst Pharmaceuticals in Q2 2024 and has held it in 10 quarters since.
11 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.

Based on May Barnhard Investments's 13F filing for Q3 2026, filed 9 Oct 2026.